Literature DB >> 11884566

Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.

Lynn J Poole1, Yanxing Yu, Peter S Kim, Qi-Zhi Zheng, Jonathan Pevsner, Gary S Hayward.   

Abstract

Kaposi's sarcoma (KS)-associated herpesvirus (KSHV; also called human herpesvirus 8) is believed to be the etiologic agent of Kaposi's sarcoma, multicentric Castleman's disease, and AIDS-associated primary effusion lymphoma. KSHV infection of human dermal microvascular endothelial cells (DMVEC) in culture results in the conversion of cobblestone-shaped cells to spindle-shaped cells, a characteristic morphological feature of cells in KS lesions. All spindle-shaped cells in KSHV-infected DMVEC cultures express the latency-associated nuclear protein LANA1, and a subfraction of these cells undergo spontaneous lytic cycle induction that can be enhanced by tetradecanoyl phorbol acetate (TPA) treatment. To study the cellular response to infection by KSHV, we used two different gene array screening systems to examine the expression profile of either 2,350 or 9,180 human genes in infected compared to uninfected DMVEC cultures in both the presence and absence of TPA. In both cases, between 1.4 and 2.5% of the genes tested were found to be significantly upregulated or downregulated. Further analysis by both standard and real-time reverse transcription-PCR procedures directly confirmed these results for 14 of the most highly upregulated and 13 of the most highly downregulated genes out of a total of 37 that were selected for testing. These included strong upregulation of interferon-responsive genes such as interferon response factor 7 (IRF7) and myxovirus resistance protein R1, plus upregulation of exodus 2 beta-chemokine, RDC1 alpha-chemokine receptor, and transforming growth factor beta3, together with strong downregulation of cell adhesion factors alpha(4)-integrin and fibronectin plus downregulation of bone morphogenesis protein 4, matrix metalloproteinase 2, endothelial plasminogen activator inhibitor 1, connective tissue growth factor, and interleukin-8. Significant dysregulation of several other cytokine-related genes or receptors, as well as endothelial cell and macrophage markers, and various other genes associated with angiogenesis or transformation was also detected. Western immunoblot and immunohistochemical analyses confirmed that the cellular IRF7 protein levels were strongly upregulated during the early lytic cycle both in KSHV-infected DMVEC and in the body cavity-based lymphoma BCBL1 PEL cell line.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884566      PMCID: PMC136008          DOI: 10.1128/jvi.76.7.3395-3420.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.

Authors:  D M Ciufo; J S Cannon; L J Poole; F Y Wu; P Murray; R F Ambinder; G S Hayward
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.

Authors:  G Taraboletti; R Benelli; P Borsotti; M Rusnati; M Presta; R Giavazzi; L Ruco; A Albini
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

3.  Characterization of the G-protein linked orphan receptor GPRN1/RDC1.

Authors:  N M Law; S A Rosenzweig
Journal:  Biochem Biophys Res Commun       Date:  1994-05-30       Impact factor: 3.575

4.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Authors:  C Bais; B Santomasso; O Coso; L Arvanitakis; E G Raaka; J S Gutkind; A S Asch; E Cesarman; M C Gershengorn; E A Mesri; M C Gerhengorn
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

5.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

6.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

Authors:  S Matsuoka; M C Edwards; C Bai; S Parker; P Zhang; A Baldini; J W Harper; S J Elledge
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

7.  Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma.

Authors:  H Pedersen; J Grøndahl-Hansen; D Francis; K Osterlind; H H Hansen; K Danø; N Brünner
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

Review 8.  Clinical aspects of epidemic Kaposi's sarcoma.

Authors:  A Buchbinder; A E Friedman-Kien
Journal:  Cancer Surv       Date:  1991

9.  Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

Authors:  H Pedersen; N Brünner; D Francis; K Osterlind; E Rønne; H H Hansen; K Danø; J Grøndahl-Hansen
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.

Authors:  S Uccini; L P Ruco; F Monardo; A Stoppacciaro; E Dejana; I L La Parola; D Cerimele; C D Baroni
Journal:  J Pathol       Date:  1994-05       Impact factor: 7.996

View more
  53 in total

1.  Inhibition of gammaherpesvirus replication by RNA interference.

Authors:  Qingmei Jia; Ren Sun
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Authors:  Brian R Lane; Jianguo Liu; Paul J Bock; Dominique Schols; Michael J Coffey; Robert M Strieter; Peter J Polverini; David M Markovitz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha.

Authors:  Frederick Y Wu; Qi-Qun Tang; Honglin Chen; Colette ApRhys; Christopher Farrell; Jianmeng Chen; Masahiro Fujimuro; M Daniel Lane; Gary S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

Review 4.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

5.  Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.

Authors:  Sean M Gregory; Ling Wang; John A West; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

Authors:  Juliene K G Co; Saguna Verma; Ulziijargal Gurjav; Laarni Sumibcay; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2007-07-20       Impact factor: 5.226

7.  Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.

Authors:  Mijung Kwon; Soo Jin Lee; Yarong Wang; Yevangelina Rybak; Alex Luna; Srilakshmi Reddy; Asha Adem; Brian T Beaty; John S Condeelis; Steven K Libutti
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

8.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.

Authors:  Patrick A Carroll; Elizabeth Brazeau; Michael Lagunoff
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.